u/userirl
Reddit r/biotech_stocks
Leaderboard rank
Open in leaderboard →| Horizon | 7D | 30D | 90D | 180D | 360D | AVG |
|---|---|---|---|---|---|---|
| Rank | — | — | — | — | — | — |
| Calls | 0/10 | 0/10 | 0/10 | 0/10 | 0/10 | 0/10 |
| Avg return | — | — | — | — | — | — |
| vs S&P 500 | — | — | — | — | — | — |
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Oct 29
$10.37
-
The author argues SLS is a binary bet on REGAL, the first randomized Phase 3 test of GPS maintenance therapy in second-remission AML, with overall survival as the endpoint. The setup is supported by credible MSK/MD Anderson researchers, financing that kept the trial funded with about $138M in cash, and a batch-manufactured peptide format that avoids Dendreon-style bespoke production risk. The immediate catalyst is REGAL top-line data due this quarter; the main risks are a trial miss given weak prior non-randomized data, another warrant-heavy dilutive raise, and approval without commercial payoff.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions
u/userirl has 1 trade ideas tracked on Buzzberg across 1 tickers since October 2026.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
